Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional, Double-Blind, Randomized Controlled Noninferiority Trial

Autor: Brian Faragher, Halidou Tinto, Dorine W. Swinkels, Sabine Gies, Salou Diallo, Yves Claeys, Adama Kazienga, Bernard J. Brabin, Sayouba Ouedraogo, Matthew Powney, Anneke Geurts-Moespot, Stephen A Roberts, Umberto D'Alessandro, Loretta Brabin
Rok vydání: 2018
Předmět:
Nonpregnant
Parasitemia
Pregnant
Adolescents
law.invention
0302 clinical medicine
Randomized controlled trial
law
Pregnancy
Immunology and Allergy
qu_188
qu_220
030212 general & internal medicine
adolescents
2. Zero hunger
wa_30
Obstetrics
Anemia
Iron deficiency
3. Good health
Women's cancers Radboud Institute for Health Sciences [Radboudumc 17]
Infectious Diseases
Female
wa_309
nonpregnant
medicine.medical_specialty
Adolescent
Iron
malaria
World Health Organization
03 medical and health sciences
Major Articles and Brief Reports
Folic Acid
All institutes and research themes of the Radboud University Medical Center
pregnant
parasitic diseases
medicine
Humans
Parasites
business.industry
medicine.disease
Malaria
wc_750
Clinical trial
Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]
Relative risk
Dietary Supplements
business
030217 neurology & neurosurgery
Zdroj: The Journal of Infectious Diseases, 218, 7, pp. 1099-1109
The Journal of Infectious Diseases, 218, 1099-1109
The Journal of Infectious Diseases
Gies, S, Diallo, S, Roberts, S A, Kazienga, A, Powney, M, Brabin, L, Ouedraogo, S, Swinkels, D W, Geurts-Moespot, A J, Claeys, Y, D'Alessandro, U, Tinto, H, Faragher, B & Brabin, B 2018, ' Effects of weekly iron and folic acid supplements on malaria risk in nulliparous women in Burkina Faso : A periconceptional, double-blind, randomized controlled noninferiority trial ', Journal of INfectious Diseases, vol. 218, no. 7, pp. 1099-1109 . https://doi.org/10.1093/infdis/jiy257
ISSN: 0022-1899
DOI: 10.1093/infdis/jiy257
Popis: Weekly iron supplementation, given to young nulliparous women living in a malaria-endemic area, neither improved iron status nor increased malaria risk, suggesting that current iron recommendations may need revisiting for these women.
Background The safety of iron supplementation for young women is uncertain in malaria-endemic settings. Methods This was a double-blind, randomized controlled noninferiority trial in rural Burkina Faso. Results A total of 1959 nulliparae were assigned to weekly supplementation (60 mg iron and 2.8 mg folic acid) (n = 980) or 2.8 mg folic acid (n = 979) until first antenatal visit (ANC1), or 18 months if remaining nonpregnant. Three hundred fifteen women attended ANC1, and 916 remained nonpregnant. There was no difference at ANC1 in parasitemia prevalence (iron, 53.4% [95% confidence interval {CI}, 45.7%–61.0%]; control, 55.3% [95% CI, 47.3%–62.9%]; prevalence ratio, 0.97 [95% CI, .79–1.18]; P = .82), anemia (adjusted effect, 0.96 [95% CI, .83–1.10]; P = .52), iron deficiency (adjusted risk ratio [aRR], 0.84 [95% CI, .46–1.54]; P = .58), or plasma iron biomarkers. Outcomes in nonpregnant women were parasitemia (iron, 42.9% [95% CI, 38.3%–47.5%]; control, 39.2% [95% CI, 34.9%–43.7%]; prevalence ratio, 1.09 [95% CI, .93–1.28]; P = .282); anemia (aRR, 0.90 [95% CI, .78–1.05]; P = .17), and iron deficiency (aRR, 0.99 [95% CI, .77–1.28]; P = .96), with no iron biomarker differences. Conclusions Weekly iron supplementation did not increase malaria risk, improve iron status, or reduce anemia in young, mostly adolescent menstruating women, nor in early pregnancy. World Health Organization Guidelines for universal supplementation for young nulliparous women may need reassessment. Clinical Trials Registration NCT01210040.
Databáze: OpenAIRE